Review
doi: 10.1007/s10147-008-0812-0.
Epub 2008 Aug 15.
Molecular pathogenesis of bladder cancer
Affiliations
- PMID: 18704628
- DOI: 10.1007/s10147-008-0812-0
Item in Clipboard
Review
Molecular pathogenesis of bladder cancer
Int J Clin Oncol.
2008 Aug.
Abstract
Bladder tumors show widely differing histopathology and clinical behavior. This is reflected in the molecular genetic alterations they contain. Much information has accumulated on somatic genomic alterations in bladder tumors of all grades and stages and when this information is related to the common histopathological appearances, a model for the pathogenesis of two major groups of bladder tumors has emerged. This review summarizes the genetic alterations that have been reported in bladder cancer and relates these to the current two-pathway model for tumor development. The molecular pathogenesis of high-grade noninvasive papillary tumors and of T1 tumors is not yet clear and possibilities are discussed.
Similar articles
-
[Tumors of the urinary system. Current and old problems].Pathologe. 2009 Dec;30 Suppl 2:179-84. doi: 10.1007/s00292-009-1192-6. Pathologe. 2009. PMID: 19960299 German.
-
Two molecular pathways to transitional cell carcinoma of the bladder.Cancer Res. 1994 Feb 1;54(3):784-8. Cancer Res. 1994. PMID: 8306342
-
[Classification and natural history of bladder tumors].Rev Prat. 2014 Dec;64(10):1365-6, 1368-71. Rev Prat. 2014. PMID: 25668829 French.
-
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.Nat Clin Pract Urol. 2006 Dec;3(12):642-52. doi: 10.1038/ncpuro0649. Nat Clin Pract Urol. 2006. PMID: 17149381 Review.
-
Genetic and molecular markers of urothelial premalignancy and malignancy.Scand J Urol Nephrol Suppl. 2000;(205):82-93. doi: 10.1080/003655900750169338. Scand J Urol Nephrol Suppl. 2000. PMID: 11144907 Review.
Cited by
-
Expression pattern of p53-binding protein 1 as a new molecular indicator of genomic instability in bladder urothelial carcinoma.Sci Rep. 2018 Oct 19;8(1):15477. doi: 10.1038/s41598-018-33761-9. Sci Rep. 2018. PMID: 30341375 Free PMC article.
-
Animal Models in Bladder Cancer.Biomedicines. 2021 Nov 24;9(12):1762. doi: 10.3390/biomedicines9121762. Biomedicines. 2021. Retraction in: Biomedicines. 2022 Jan 06;10(1):110. doi: 10.3390/biomedicines10010110 PMID: 34944577 Free PMC article. Retracted. Review.
-
Contemporary management of low-risk bladder cancer.Nat Rev Urol. 2011 Jan;8(1):42-9. doi: 10.1038/nrurol.2010.208. Nat Rev Urol. 2011. PMID: 21228821 Review.
-
Novel strategies for treating relapsed/refractory urothelial carcinoma.Expert Rev Anticancer Ther. 2010 Dec;10(12):1917-32. doi: 10.1586/era.10.182. Expert Rev Anticancer Ther. 2010. PMID: 21110758 Free PMC article. Review.
-
Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena.Philos Trans R Soc Lond B Biol Sci. 2015 Feb 5;370(1661):20140042. doi: 10.1098/rstb.2014.0042. Philos Trans R Soc Lond B Biol Sci. 2015. PMID: 25533099 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
